If you're not already pissed off by the astronomical price increase of a decades-old lifesaving medicine, well, you really should be.
The drug, known as Daraprim, has long been used as the standard treatment for a life-threatening parasitic infection called toxoplasmosis, especially among HIV and cancer patients. After acquiring the drug last month, Turing Pharmaceuticals raised the price from $13.50 per tablet to $750, angering doctors, infectious disease experts, and patients who fear they won't be able to afford the medication when they need it. Even Democratic presidential hopeful Hillary Clinton slammed the decision.
"The reason is nothing more than this guy saw a hole in the market he could exploit... it’s just garbage and he knows it."
Despite the intense criticism, Martin Shkreli, a former hedge fund manager and CEO of the pharmaceutical startup, has remained defiant -- even calling a reporter a "moron"
after he asked Shkreli to explain the increase, which probably didn't help the situation. Shkreli responded to criticism on Twitter by posting
Eminem’s “The Way I Am," like a kind-hearted CEO, and in an interview with CBS News on Tuesday, he defended the move as merely a good business decision that will result in a "reasonable profit." For perspective, the average cost of treatment with Daraprim went from $1,130 to $63,000 and even eclipsing $600,000 for some patients, according to the report